{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/49437"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/49437","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Hippo pathway Inactivation drives basal-like mammary tumorigenesis","abstract":"Basal-like breast cancers make up an aggressive subtype of breast cancer with diverse intratumor cell heterogeneity and poor clinical outcomes. These cancers are predominantly triple-negative cancers such that they lack expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2). Evidence suggests that basal-like cancers arise from luminal mammary epithelial cells that acquire basal-like traits during tumorigenesis, a process known as cell plasticity. These cancers also present with dramatic remodeling of stromal cell populations such as fibroblasts and immune cells, which become rewired to form a pro-tumorigenic niche. An improved understanding of the cellular mechanisms that drive epithelial plasticity and stromal remodeling may therefore help advance treatment avenues for basal-like breast cancer. This dissertation describes important roles for the Hippo signaling pathway, a pathway involved in development and stem cell traits, in basal-like breast cancer pathogenesis. Using genetic mouse models, we demonstrate that deletion of the Hippo pathway kinases large tumor suppressor kinase (LATS)1 and LATS2 (LATS1/2) in mammary luminal epithelial cells leads to luminal-basal plasticity and the development of basal-like carcinomas through activation of the transcriptional regulators yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ). These carcinomas are accompanied by remodeling of the mammary stroma, including an accumulation of cancer-associated fibroblasts and a distinct deposition of extracellular matrix. We further present analyses suggesting that LATS1/2 inactivation promotes a tumor-associated niche through reciprocal epithelial-stromal signaling. Together, these results implicate the Hippo pathway as a critical mediator of homeostasis in the mammary gland and suggest that Hippo dysregulation drives basal-like breast cancer initiation by promoting mammary epithelial transformation and stromal remodeling.","abstract_html":"Basal-like breast cancers make up an aggressive subtype of breast cancer with diverse intratumor cell heterogeneity and poor clinical outcomes. These cancers are predominantly triple-negative cancers such that they lack expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2). Evidence suggests that basal-like cancers arise from luminal mammary epithelial cells that acquire basal-like traits during tumorigenesis, a process known as cell plasticity. These cancers also present with dramatic remodeling of stromal cell populations such as fibroblasts and immune cells, which become rewired to form a pro-tumorigenic niche. An improved understanding of the cellular mechanisms that drive epithelial plasticity and stromal remodeling may therefore help advance treatment avenues for basal-like breast cancer. This dissertation describes important roles for the Hippo signaling pathway, a pathway involved in development and stem cell traits, in basal-like breast cancer pathogenesis. Using genetic mouse models, we demonstrate that deletion of the Hippo pathway kinases large tumor suppressor kinase (LATS)1 and LATS2 (LATS1/2) in mammary luminal epithelial cells leads to luminal-basal plasticity and the development of basal-like carcinomas through activation of the transcriptional regulators yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ). These carcinomas are accompanied by remodeling of the mammary stroma, including an accumulation of cancer-associated fibroblasts and a distinct deposition of extracellular matrix. We further present analyses suggesting that LATS1/2 inactivation promotes a tumor-associated niche through reciprocal epithelial-stromal signaling. Together, these results implicate the Hippo pathway as a critical mediator of homeostasis in the mammary gland and suggest that Hippo dysregulation drives basal-like breast cancer initiation by promoting mammary epithelial transformation and stromal remodeling.","abstract_has_math":false,"creators":["Kern, Joseph George"],"institution":"Boston University","degree_name":"Doctor of Philosophy","degree_level":"doctoral","degree_discipline":"Biochemistry","degree_department":null,"school":null,"contributors":[],"advisors":["Varelas, Xaralabos"],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023","date_published":"2023","updated_at":"2026-11-19T02:41:58Z","subjects":["Cellular biology","Breast","Cancer","Hippo","Mammary","Microenvironment","Plasticity"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0003-2291-6020"],"render_values":[{"text":"0000-0003-2291-6020","href":"https://orcid.org/0000-0003-2291-6020","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/2144/49437","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/49437","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F49437","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Varelas, Xaralabos"]},{"key":"dc:creator","label":"Author","values":["Kern, Joseph George"]},{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0003-2291-6020"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2024-11-01T16:27:20Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2025-10-29T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2023"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2024-10-30T16:02:05Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Cellular biology","Breast","Cancer","Hippo","Mammary","Microenvironment","Plasticity"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/49437"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Basal-like breast cancers make up an aggressive subtype of breast cancer with diverse intratumor cell heterogeneity and poor clinical outcomes. These cancers are predominantly triple-negative cancers such that they lack expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2). Evidence suggests that basal-like cancers arise from luminal mammary epithelial cells that acquire basal-like traits during tumorigenesis, a process known as cell plasticity. These cancers also present with dramatic remodeling of stromal cell populations such as fibroblasts and immune cells, which become rewired to form a pro-tumorigenic niche. An improved understanding of the cellular mechanisms that drive epithelial plasticity and stromal remodeling may therefore help advance treatment avenues for basal-like breast cancer. This dissertation describes important roles for the Hippo signaling pathway, a pathway involved in development and stem cell traits, in basal-like breast cancer pathogenesis. Using genetic mouse models, we demonstrate that deletion of the Hippo pathway kinases large tumor suppressor kinase (LATS)1 and LATS2 (LATS1/2) in mammary luminal epithelial cells leads to luminal-basal plasticity and the development of basal-like carcinomas through activation of the transcriptional regulators yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ). These carcinomas are accompanied by remodeling of the mammary stroma, including an accumulation of cancer-associated fibroblasts and a distinct deposition of extracellular matrix. We further present analyses suggesting that LATS1/2 inactivation promotes a tumor-associated niche through reciprocal epithelial-stromal signaling. Together, these results implicate the Hippo pathway as a critical mediator of homeostasis in the mammary gland and suggest that Hippo dysregulation drives basal-like breast cancer initiation by promoting mammary epithelial transformation and stromal remodeling."]},{"key":"dc:title","label":"Title","values":["Hippo pathway Inactivation drives basal-like mammary tumorigenesis"]}]}],"canonical_facts":{"dc:contributor.advisor":["Varelas, Xaralabos"],"dc:creator":["Kern, Joseph George"],"dc:date.accessioned":["2024-11-01T16:27:20Z"],"dc:date.embargo":["2025-10-29T00:00:00Z"],"dc:date.issued":["2023"],"dc:date.updated":["2024-10-30T16:02:05Z"],"dc:description.abstract":["Basal-like breast cancers make up an aggressive subtype of breast cancer with diverse intratumor cell heterogeneity and poor clinical outcomes. These cancers are predominantly triple-negative cancers such that they lack expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2). Evidence suggests that basal-like cancers arise from luminal mammary epithelial cells that acquire basal-like traits during tumorigenesis, a process known as cell plasticity. These cancers also present with dramatic remodeling of stromal cell populations such as fibroblasts and immune cells, which become rewired to form a pro-tumorigenic niche. An improved understanding of the cellular mechanisms that drive epithelial plasticity and stromal remodeling may therefore help advance treatment avenues for basal-like breast cancer. This dissertation describes important roles for the Hippo signaling pathway, a pathway involved in development and stem cell traits, in basal-like breast cancer pathogenesis. Using genetic mouse models, we demonstrate that deletion of the Hippo pathway kinases large tumor suppressor kinase (LATS)1 and LATS2 (LATS1/2) in mammary luminal epithelial cells leads to luminal-basal plasticity and the development of basal-like carcinomas through activation of the transcriptional regulators yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ). These carcinomas are accompanied by remodeling of the mammary stroma, including an accumulation of cancer-associated fibroblasts and a distinct deposition of extracellular matrix. We further present analyses suggesting that LATS1/2 inactivation promotes a tumor-associated niche through reciprocal epithelial-stromal signaling. Together, these results implicate the Hippo pathway as a critical mediator of homeostasis in the mammary gland and suggest that Hippo dysregulation drives basal-like breast cancer initiation by promoting mammary epithelial transformation and stromal remodeling."],"dc:identifier.orcid":["0000-0003-2291-6020"],"dc:identifier.uri":["https://hdl.handle.net/2144/49437"],"dc:language.iso":["en_US"],"dc:subject":["Cellular biology","Breast","Cancer","Hippo","Mammary","Microenvironment","Plasticity"],"dc:title":["Hippo pathway Inactivation drives basal-like mammary tumorigenesis"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Biochemistry"],"thesis:degree_level":["doctoral"],"thesis:degree_name":["Doctor of Philosophy"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:41:58Z"}